Important Notice: Opine Online provides an
informal way for the research community to express its views on current topics.
The results are not a scientific poll and do not necessarily reflect the percentages
of all Alzheimer researchers who agree with these positions.
Poll Question: Should the FDA be allowed to use data from overseas clinical trials?
Absolutely, we are running out of viable subjects in the U.S.
Yes, so long as the data is reliable
No, the trials are not as rigorous
No, the data should be repeated in the U.S.
No, the drug sponsors are just trying to cut corners
Yes, it is much better to have data from different study settings, across populations and cultures, so long as the data are reliable. Then, the findings can be generalized to worldwide study populations.